Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia

Department of Psychiatry and Human Behavior, Functional Genomics Laboratory, College of Medicine, University of California, Irvine, CA 92697, USA.
Human Genetics (Impact Factor: 4.82). 07/2006; 119(5):558-70. DOI: 10.1007/s00439-006-0172-7
Source: PubMed


Multiple linkage regions have been reported in schizophrenia, and some appear to harbor susceptibility genes that are differentially expressed in postmortem brain tissue derived from unrelated individuals. We combined traditional genome-wide linkage analysis in a multiplex family with lymphocytic genome-wide expression analysis. A genome scan suggested linkage to a chromosome 4q marker (D4S1530, LOD 2.17, theta = 0) using a dominant model. Haplotype analysis using flanking microsatellite markers delineated a 14 Mb region that cosegregated with all those affected. Subsequent genome-wide scan with SNP genotypes supported the evidence of linkage to 4q33-35.1 (LOD = 2.39) using a dominant model. Genome-wide microarray analysis of five affected and five unaffected family members identified two differentially expressed genes within the haplotype AGA and GALNT7 (aspartylglucosaminidase and UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7) with nominal significance; however, these genes did not remain significant following analysis of covariance. We carried out genome-wide linkage analyses between the quantitative expression phenotype and genetic markers. AGA expression levels showed suggestive linkage to multiple markers in the haplotype (maximum LOD = 2.37) but to no other genomic region. GALNT7 expression levels showed linkage to regulatory loci at 4q28.1 (maximum LOD = 3.15) and in the haplotype region at 4q33-35.1 (maximum LOD = 2.37). ADH1B (alcohol dehydrogenase IB) was linked to loci at 4q21-q23 (maximum LOD = 3.08) and haplotype region at 4q33-35.1 (maximum LOD = 2.27). Seven differentially expressed genes were validated with RT-PCR. Three genes in the 4q33-35.1 haplotype region were also differentially expressed in schizophrenia in postmortem dorsolateral prefrontal cortex: AGA, HMGB2, and SCRG1. These results indicate that combining differential gene expression with linkage analysis may help in identifying candidate genes and potential regulatory sites. Moreover, they also replicate recent findings of complex trans- and cis- regulation of genes.

Download full-text


Available from: Ling Shao, Jul 03, 2014
  • Source
    • "CD14 antigen, chemokine receptor 1) Zvara et al., 2005 Lymphocytes 13 drug-naïve/drug-free schizophrenia patients Genes for dopamine receptor D2 (DRD2) and the inwardly rectifying potassium channel (Kir2.3) were over-expressed Vawter et al., 2006 Lymphocytes Multiplex pedigree study of 5 haplotype-positive individuals with schizophrenia, 5 unaffected haplotype-negative controls AGA expression levels showed suggestive linkage to multiple markers in the haplotype; GALNT7 expression levels showed linkage to regulatory loci at 4q28.1 and in the haplotype region at 4q33−35.1 Bowden et al., 2006 Lymphocytes 14 schizophrenia and 14 matched controls 18 genes with brain-related functions were altered in schizophrenia versus controls; 4 of which, endothelial differentiation gene 2 (Edg-2), ezrin-radixin-moesin phosphoprotein 50 (EBP50), myc-associated zinc finger protein (MAZ) and tumor necrosis factor receptor 2 (TNFR2), were confirmed by relative real-time PCR McCurdy et al., 2006 Olfactory neuroepithelium 10 schizophrenia, 8 bipolar and 9 matched control subjects Genes associated with vesicle-mediated transport, cell proliferation, neurogenesis, apoptosis and inositol phosphate metabolism/ phosphatidylinositol signalling were most significantly dysregulated in schizophrenia Matigian et al., 2008 Lymphoblasts and fibroblasts 16 schizophrenia patients and 14 matched controls No significantly different expression in schizophrenia versus controls Yao et al., 2008 Blood mononuclear cells 30 first-admission schizophrenia patients and 26 healthy control subjects Increased chemokine (C-X-C motif) ligand 1 (CXCL1) expression in schizophrenia confirming findings reported by Tsuang et al. (2005) Glatt et al., 2009 Blood mononuclear cells 13 schizophrenia, 9 bipolar disorder and 8 healthy control subjects Significant interaction between diagnostic group and exon identity, with 33 genes showing differential splicing patterns between schizophrenia and bipolar disorder samples Bousman et al., 2010 Blood mononuclear cells 24 schizophrenia, 23 bipolar disorder, 25 h10 91/F6 nonuclear cellsdep1 Trourder andy, with 33 genes "
    [Show abstract] [Hide abstract]
    ABSTRACT: With an estimated 80% heritability, molecular genetic research into schizophrenia has remained inconclusive. Recent large-scale, genome-wide association studies only identified a small number of susceptibility genes with individually very small effect sizes. However, the variable expression of the phenotype is not well captured in diagnosis-based research as well as when assuming a 'heterogenic risk model' (as apposed to a monogenic or polygenic model). Hence, the expression of susceptibility genes in response to environmental factors in concert with other disease-promoting or protecting genes has increasingly attracted attention. The current review summarises findings of microarray gene expression research with relevance to schizophrenia as they emerged over the past decade. Most findings from post mortem, peripheral tissues and animal models to date have linked altered gene expression in schizophrenia to presynaptic function, signalling, myelination, neural migration, cellular immune mechanisms, and response to oxidative stress consistent with multiple small effects of many individual genes. However, the majority of results are difficult to interpret due to small sample sizes (i.e. potential type-2 errors), confounding factors (i.e. medication effects) or lack of plausible neurobiological theory. Nevertheless, microarray gene expression research is likely to play an important role in the future when investigating gene/gene and gene/environment interactions by adopting a neurobiologically sound theoretical framework.
    Australian and New Zealand Journal of Psychiatry 03/2012; 46(7):598-610. DOI:10.1177/0004867412442405 · 3.41 Impact Factor
  • Source
    • "Microarray studies in postmortem brains of subjects with schizophrenia have implicated altered gene expression in pathways involved in myelination [1], GABAergic and glutamatergic transmission [2,3], synaptic plasticity [4,5] and metabolic pathways [6-8] [for review see [9]]. While examining gene expression in brain tissue from subjects with psychiatric or neurological disorders might be more relevant to disease pathology, assessment of whole blood or lymphocyte gene expression has several advantages, including practical availability of blood compared to brain tissue in human subjects and reduced confounds such as post-mortem interval (PMI), pH and agonal factors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to examine the effects of glucose reduction stress on lymphoblastic cell line (LCL) gene expression in subjects with schizophrenia compared to non-psychotic relatives. LCLs were grown under two glucose conditions to measure the effects of glucose reduction stress on exon expression in subjects with schizophrenia compared to unaffected family member controls. A second aim of this project was to identify cis-regulated transcripts associated with diagnosis. There were a total of 122 transcripts with significant diagnosis by probeset interaction effects and 328 transcripts with glucose deprivation by probeset interaction probeset effects after corrections for multiple comparisons. There were 8 transcripts with expression significantly affected by the interaction between diagnosis and glucose deprivation and probeset after correction for multiple comparisons. The overall validation rate by qPCR of 13 diagnosis effect genes identified through microarray was 62%, and all genes tested by qPCR showed concordant up- or down-regulation by qPCR and microarray. We assessed brain gene expression of five genes found to be altered by diagnosis and glucose deprivation in LCLs and found a significant decrease in expression of one gene, glutaminase, in the dorsolateral prefrontal cortex (DLPFC). One SNP with previously identified regulation by a 3' UTR SNP was found to influence IRF5 expression in both brain and lymphocytes. The relationship between the 3' UTR rs10954213 genotype and IRF5 expression was significant in LCLs (p = 0.0001), DLPFC (p = 0.007), and anterior cingulate cortex (p = 0.002). Experimental manipulation of cells lines from subjects with schizophrenia may be a useful approach to explore stress related gene expression alterations in schizophrenia and to identify SNP variants associated with gene expression.
    BMC Medical Genomics 09/2009; 2(1):62. DOI:10.1186/1755-8794-2-62 · 2.87 Impact Factor
  • Source
    • "Several proteins with not explored functions and no previously reported connections to EAAC1, e.g. Galnt7 [24], microfibrillar associated protein 3, ANK repeat, and LEM domain-containing protein. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Excitatory amino acid carrier 1 (EAAC1) is a glutamate transporter found in neuronal tissues and is extensively expressed in the retina. EAAC1 plays a role in a variety of neural functions, but its biological functions in the retina has not been fully determined. The purpose of this study was to identify proteins regulated by EAAC1 in the retina of mice. To accomplish this, we used a proteomics-based approach to identify proteins that are up- or down-regulated in EAAC1-deficient (EAAC1-/-) mice. Proteomic analyses and two-dimensional gel electorphoresis were performed on the retina of EAAC1-/- mice, and the results were compared to that of wild type mice. The protein spots showing significant differences were selected for identification by mass spectrometric analyses. Thirteen proteins were differentially expressed; nine proteins were up-regulated and five proteins were down-regulated in EAAC1-/- retina. Functional clustering showed that identified proteins are involved in various cellular process, e.g. cell cycle, cell death, transport and metabolism. We identified thirteen proteins whose expression is changed in EAAC-/- mice retinas. These proteins are known to regulate cell proliferation, death, transport, metabolism, cell organization and extracellular matrix.
    Proteome Science 02/2007; 5(1):13. DOI:10.1186/1477-5956-5-13 · 1.73 Impact Factor
Show more